Rheumatology

Radiation Oncology

Questions discussed in this category

How would you treat a recurrent endometrial cancer at the vaginal cuff that was initially FIGO 1A with no adj treatment, in a patient with actively treated scleroderma?

3 Answers available

How do you approach the use of parathyroid hormone-related protein analog drugs in the setting of prior external beam radiation?

If you avoid parathyroid hormone-related protein analog drugs in patients with prior external beam radiation, what data is this based on?

1 Answer available

Would you offer palliative radiation for painful bone metastases in a patient with scleroderma?

1 Answer available

Is active rheumatoid arthritis (RA) a contraindication to hypofractionated breast irradiation?

How does a diagnosis of active RA inform your treatment approach for patients with breast cancer, if at all?

4 Answers available

Would you consider continuing a biologic for difficult to control autoimmune disease in a patient with a recent diagnosis of a surgically curable solid malignancy?

Would you favor the use of any particular biologics over others?

1 Answer available

How would you approach a patient with gastric MALT lymphoma who has CREST syndrome?

Would chemotherapy be preferred over RT?

2 Answers available

How would you approach definitive treatment of intermediate-risk prostate cancer with baseline severe (AUA >25) urinary dysfunction and severe rheumatoid arthritis?

Would your answer change for favorable vs unfavorable intermediate risk disease?

1 Answer available

Do you advise patients to hold DMARDs for conditions such as psoriasis or rheumatoid arthritis while actively undergoing radiation treatment?

Does it depend on the DMARD type (biologic, targeted synthetic, or conventional synthetic)?

2 Answers available

Should TNF inhibitors be held in patients undergoing radiation therapy?

Is there a risk of increased radioresistance or secondary malignancy (or conversely, toxicity) for patients on TNF inhibitors...

1 Answer available

What is your strategy to prevent and treat constipation in patients initiating or receiving opioids?

What non-pharmacological interventions do you recommend? Do you routinely prescribe prophylactic laxatives to patients initiating opioids? How do you ...

3 Answers available

Would you offer lung SBRT to a medically inoperable patient with systemic lupus erythematosus or other connective tissue disorders if well controlled?

If so, do you take any additional precautions with planning?

1 Answer available

Would you avoid radiation in a patient with breast cancer with active skin lupus?

In a patient with early stage breast cancer that would otherwise require radiation, would you recommend treatment if the patient has active skin lupus...

1 Answer available

In light of promising results of hydroxychloroquine in COVID-19, should we consider using it prophylactically in cancer patients, especially if immunocompromised?

Acknowledging that there is no time for good trials yet in this setting

1 Answer available

Would you offer lung SBRT for an individual with rheumatoid arthritis?

Also, how would you handle immune modulators for rheumatoid arthritis during their treatment?

1 Answer available

How do you approach post operative radiation therapy to someone with head and neck cancer who has high risk of local recurrence who also has scleroderma?

Is there any literature on the safety of giving radiation to patients with scleroderma in H&N setting?

1 Answer available

How does the presence of active rheumatoid arthritis on rituxan impact your decision to proceed with prostate radiation?

Would you require the rituxan to be held prior to radiation? Would this matter if it was in the post-prostatectomy setting?

1 Answer available

How do you identify immunotherapy-related pneumonitis vs. radiation pneumonitis in a patient status post chemoradiation receiving consolidation immunotherapy?

Is IO related pneumonitis in the radiation field or more diffuse?

1 Answer available

Does the presence of a connective tissue disorder such as lupus or scleroderma modify your radiation dose or technique for prostate cancer?

2 Answers available

How would the presence of active rheumatoid arthritis on methotrexate impact your choice of fractionation for a patient with prostate cancer?

1 Answer available

How do you counsel an early stage breast cancer patient with lupus regarding decisions on radiation?

3 Answers available

Is chronic methotrexate for rheumatoid arthritis a contraindication for prostate brachytherapy?

Are there any other medications, outside of anticoagulation, that would be considered absolute or relative contraindications?

2 Answers available

Should methotrexate be stopped prior to radiation therapy if a patient has rheumatoid arthritis?

1 Answer available

Is hypofractionation ever appropriate in women with early stage breast cancer and latent lupus who have never experienced skin symptoms in their lifetime?

Do you always stick with a conventional fracionation, or in some cases, are you comfortable hypofractionating? Do you ever use a wait and see approach...

1 Answer available

Do you consider APBI a reasonable alternative to mastectomy for women with early stage breast cancer and collagen vascular diseases?

Do you put more weight on specific CVDs such as scleroderma as contraindications for any RT?

1 Answer available

How do you manage patients with early stage breast cancer with autoimmune disorders such as rheumatoid arthritis and collagen vascular disorders?

Do you have any concern for increased toxicity when you treat a patient with radiation therapy who has an autoimmune disorder? (hypofractiationation v...

1 Answer available